Prostatic Artery Embolization Obviates the Need for Androgen Deprivation Therapy prior to Stereotactic Body Radiation Therapy in Prostate Cancer

Prostatic artery embolization (PAE) is a safe and efficacious treatment for moderate to severe lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) refractory to medical therapy, including those in patients with multiple comorbidities who are poor surgical candidates or have large prostates (>80 mL) (1). Stereotactic body radiation therapy (SBRT) delivers high-dose radiation over a short time course, providing prostate cancer treatment outcomes similar to those in conventional external beam radiation therapy (EBRT) or brachytherapy (2).
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Letter to the Editor Source Type: research

Related Links:

CONCLUSIONS: Although, the achieved results of this investigation demonstrated that the two examined genetic variants do not seem to be suitable markers for early diagnosis of prostate cancer in this pilot study; however increased risk for the disease is shown in GA heterozygotes and smokers which is indicative of some epigenetic factors influence on prostate cancer etiology. PMID: 31594215 [PubMed - as supplied by publisher]
Source: Human Antibodies - Category: Biochemistry Tags: Hum Antibodies Source Type: research
ConclusionsThe data shows promise of urine cell-free and vesicle cargo miRNA as prostate cancer biomarkers.Legal entity responsible for the studyThe authors.FundingThe study was supported by the Russian Science Foundation (no. 16-15-00124). Pavel P. Laktionov acknowledges financial support within the framework of the Russian state funded budget project # АААА-А17-117020210026-2 to the ICBFM SB RAS.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
To the Editor I would like to offer 2 points to expand on the important analysis by Sarkar and colleagues. First, use of a single prostate-specific antigen (PSA) multiplier for all men using 5 α-reductase inhibitors (5-ARIs) is probably not optimal. The goal is to estimate what each man’s PSA would have been in the absence of drug treatment. However, because 5-ARIs inhibit the common age-associated increase in gland volume and PSA, the PSA trajectory for a man being treated with a drug vs his counterfactual trajectory with no drug diverge over time. Furthermore, the benign prostatic hyperplasia component of tot...
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research
This article is protected by copyright. All rights reserved
Source: Proteomics - Category: Biochemistry Authors: Tags: Research Article Source Type: research
This study outperforms the conventional PSA test with a minimally invasive widely exploitable approach.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
Publication date: Available online 20 September 2019Source: Biosensors and BioelectronicsAuthor(s): Zhen Rong, Zikun Bai, Jianing Li, Hao Tang, Tianyi Shen, Qiong Wang, Chongwen Wang, Rui Xiao, Shengqi WangAbstractSimultaneous detection of free and complexed prostate-specific antigen (f-PSA and c-PSA) is critical to the prostate cancer (PCa) diagnostic accuracy for clinical samples with PSA values in the diagnostic gray zone between 4 and 10 ng mL−1. Herein, red and green magnetic-quantum dot nanobeads (MQBs) with superior magnetic property and high luminescence were fabricated via polyethyleneimine-intermediated...
Source: Biosensors and Bioelectronics - Category: Biotechnology Source Type: research
Abstract Prostate cancer (PCa) incidence has been rising in Chinese population. Current PSA-based biopsy has limited positive rate. Our research focused on development of serum markers for the diagnosis of PCa in patients with elevated PSA. miRNAs are found to be aberrantly expressed in many types of cancer. They are readily detectable in plasma and serum. Currently, miRNAs are being evaluated as potential prognostic and diagnostic tools for many types of cancer. We first profiled global serum miRNAs in a pilot set of PCa and benign prostatic hyperplasia (BPH) cases undergoing TRUS-guided prostate biopsy due to el...
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
CONCLUSIONS: Inflammatory markers can be predictive factors in the diagnosis of PCa, although more studies are needed for their routine use. PMID: 31475674 [PubMed - in process]
Source: Archivos Espanoles de Urologia - Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research
In this study, we aim to explore the molecular mechanism of NEAT1 in the development of PCa. We detected the expression levels of NEAT1 in a total of 16 benign prostatic hyperplasia tissues (BPH),30 matched adjacent healthy control (HC) tissues and 30 prostate cancer (PCa) tissues, as well as PCa cell lines PC-3, DU-145, LNCaP and normal prostate epithelial cell line RWPE-1. The results showed that NEAT1 was significantly up-regulated in PCa tissues and PCa cell lines. Knockdown of NEAT1 can largely inhibit DU-145 and PC-3 cell growth and invasion. Bioinformatics analysis predicted NEAT1 has the bindind site of miR-98-5p...
Source: Bioscience Reports - Category: Biomedical Science Authors: Tags: Biosci Rep Source Type: research
In this study, we investigated the effect of Aconiti Lateralis Radix Preparata (dried root of Aconitum carmichaelii Debx.; AL), which is an herb used to treat extremely cold symptoms in traditional Korean medicine, on BPH using a testosterone propionate- (TP-) induced BPH rat model. Eight-week inguinal injection of TP induced BPH in rats, the prostate of which was displaying an abnormal proliferation. The pathological proliferation of the prostate was ameliorated by AL treatment of 4 weeks. Pathohistological changes in the prostate including epithelial thickness and lumen area were restored in AL-treated rats. Furthermore,...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
More News: Benign Prostatic Hyperplasia | Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Prostate Cancer | Radiation Therapy | Radiology